Publication:
Tumour necrosis factor gene polymorphism in dengue infection: Association with risk of bleeding

dc.contributor.authorAmpaiwan Chuansumriten_US
dc.contributor.authorNattachai Anantasiten_US
dc.contributor.authorWerasak Sasanakulen_US
dc.contributor.authorWathanee Chaiyaratanaen_US
dc.contributor.authorKanchana Tangnararatchakiten_US
dc.contributor.authorPunnee Butthepen_US
dc.contributor.authorSirichan Chunhakanen_US
dc.contributor.authorSutee Yoksanen_US
dc.contributor.otherMahidol Universityen_US
dc.date.accessioned2018-10-19T05:25:15Z
dc.date.available2018-10-19T05:25:15Z
dc.date.issued2013-05-01en_US
dc.description.abstractBackground: A single nucleotide polymorphism located at the promoter -308A of tumour necrosis factor-alpha (TNF-α) gene may affect transcription and increase cytokine production, leading to the severe manifestation of dengue virus infection. Aim: To study the association of the TNF-α -308A allele and the severity of patients with dengue infection. Methods: 112 patients suspected of having dengue infection and 106 normal controls were enrolled in the study. Mean (SD) age was 10.4 (3.6) years. In all, 19 and 82 patients were diagnosed with dengue fever (DF) and dengue haemorrhagic fever (DHF), respectively, while 11 were diagnosed with other febrile illnesses (OFIs). They were tested for the polymorphisms at the promoter -308 position of the TNF-α gene and their TNF-α levels were measured. Results: In the patients with dengue infection (14/202, 6.9%) with OFIs (1/22, 4.5%) and in normal controls (17/212, 8.0%), the frequency of the TNF-α -308A allele was not significantly different. Moreover, no statistically significant difference was found in patients with various clinical manifestations of dengue infection involving DF (5.3%, 2/38), DHF grade I (5.0%, 2/40), DHF grade II (9.5%, 4/42), DHF grade III (2.5%, 1/40) and DHF grade IV (11.9%, 5/42). However, patients with dengue infection and significant bleeding manifestations, apart from petechiae and ecchymosis, tended to have a higher frequency of the TNF-α -308A allele (11.8%, 9/76) than those without significant bleeding manifestations (5/126, 4.0%) (P = 0.056). The levels of TNF-α were additionally measured in 67 patients but the results failed to demonstrate a functional effect in the transcriptional rate of the TNF-α -308A allele. Conclusion: In patients with dengue infection there is an association between the TNF-α -308A allele and the risk of bleeding. The test may be used as one of the predictors of the severity of dengue infection. © W. S. Maney & Son Ltd 2013.en_US
dc.identifier.citationPaediatrics and International Child Health. Vol.33, No.2 (2013), 97-101en_US
dc.identifier.doi10.1179/2046905512Y.0000000049en_US
dc.identifier.issn20469055en_US
dc.identifier.issn20469047en_US
dc.identifier.other2-s2.0-84877989873en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/32358
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877989873&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleTumour necrosis factor gene polymorphism in dengue infection: Association with risk of bleedingen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84877989873&origin=inwarden_US

Files

Collections